Your session is about to expire
← Back to Search
Rapid Fentanyl Testing Intervention for Opioid Overdose (RAPIDS Trial)
N/A
Waitlist Available
Led By Brandon DL Marshall, PhD
Research Sponsored by Brown University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post-randomization
Awards & highlights
RAPIDS Trial Summary
This trial will test a new way to prevent overdoses among people who use drugs, by incorporating rapid fentanyl testing into an educational intervention. The goal is to reduce rates of overdose compared to standard education and naloxone distribution.
Who is the study for?
This trial is for people aged 18-65 in Rhode Island who use drugs like heroin, illicit stimulants, counterfeit pills, or inject drugs and can consent to participate. It's not for those who only misuse prescription meds from a doctor or someone else's prescription.Check my eligibility
What is being tested?
The study tests a new intervention called RAPIDS that includes rapid fentanyl testing alongside standard overdose education and naloxone distribution (OEND) to see if it better prevents overdoses among drug users.See study design
What are the potential side effects?
Since this trial focuses on prevention education and drug-checking interventions rather than medication, traditional side effects are not the focus; however, there may be psychological impacts from learning about drug contamination.
RAPIDS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months post-randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post-randomization
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accidental non-fatal overdose in the past month
Secondary outcome measures
The number of fatal overdose events
RAPIDS Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: RAPIDS interventionExperimental Treatment2 Interventions
Participants randomized to receive the RAPIDS intervention will receive a fentanyl specific behavioral intervention and a brief behavioral intervention to increase willingness to use fentanyl test strips and engage in overdose risk reduction behaviors, in addition to standard OEND.
Group II: Standard OENDActive Control1 Intervention
In the control arm participants will receive standard overdose education and naloxone distribution (OEND).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Standard OEND
2020
N/A
~510
RAPIDS Intervention
2020
N/A
~510
Find a Location
Who is running the clinical trial?
Brown UniversityLead Sponsor
456 Previous Clinical Trials
562,572 Total Patients Enrolled
1 Trials studying Opioid Overdose
39 Patients Enrolled for Opioid Overdose
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,124 Total Patients Enrolled
6 Trials studying Opioid Overdose
970 Patients Enrolled for Opioid Overdose
Brandon DL Marshall, PhDPrincipal InvestigatorBrown University
2 Previous Clinical Trials
132 Total Patients Enrolled
1 Trials studying Opioid Overdose
39 Patients Enrolled for Opioid Overdose
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have used illegal drugs such as heroin, stimulants, fake prescription pills, or injected drugs in the last 30 days.You are taking medicine that is not prescribed to you by a doctor or are using someone else's prescription medication.
Research Study Groups:
This trial has the following groups:- Group 1: RAPIDS intervention
- Group 2: Standard OEND
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there particular types of people who are optimally suited to participate in this research?
"This research is open to those aged between 18 and 65 who have experienced a drug overdose. Upwards of 500 people are expected to join this experiment."
Answered by AI
How many individuals are actively enrolled in this experiment?
"Affirmative. Clinicaltrials.gov records indicate that this research endeavour, originally posted on August 31st 2020, is presently searching for 500 individuals at 1 medical centre."
Answered by AI
Is there still availability for patients to partake in this clinical trial?
"Affirmative. Clinicaltrials.gov reports that this clinical study, initially posted on August 31st 2020 is currently recruiting participants. 500 patients need to be enrolled from a single site."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger